• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharma (NQ: COLL )

    31.79 -0.03 (-0.09%)
    Streaming Delayed Price Updated: 3:18 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Collegium Pharma

    < Previous 1 2 Next >
    Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews
    Via Benzinga
    COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
    COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
    Via Benzinga
    Where Collegium Pharmaceutical Stands With Analysts
    Via Benzinga
    Recap: Collegium Pharmaceutical Q4 Earnings
    Via Benzinga
    Analyst Expectations For Collegium Pharmaceutical's Future
    Via Benzinga
    Why Collegium Pharmaceutical Shares Are Gaining Today
    Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial  
    Via Benzinga
    Recap: Collegium Pharmaceutical Q3 Earnings
    Via Benzinga
    Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know
    Via Benzinga
    Recap: Collegium Pharmaceutical Q1 Earnings
    Via Benzinga
    TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
    U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Earnings Outlook For Collegium Pharmaceutical
    Via Benzinga
    Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
    Via Benzinga
    Recap: Collegium Pharmaceutical Q1 Earnings
    Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Why Collegium Pharmaceutical's Shares Are Trading Higher Today
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
      
    Via Benzinga
    7 Micro-Cap Stocks to Take a Chance on Now
    Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors. 
    Via InvestorPlace
    A Preview Of Collegium Pharmaceutical's Earnings
    Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    5 Value Stocks To Watch In The Healthcare Sector
    What Defines a Value Stock? 
    Via Benzinga
    5 Value Stocks To Watch In The Healthcare Sector
    What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
    Via Benzinga
    Analyst Ratings For Collegium Pharmaceutical
    Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
    Via Benzinga
    The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
    Via Benzinga
    10 Biggest Price Target Changes For Tuesday
    JP Morgan raised Ralph Lauren Corporation (NYSE: RL) price target from $137 to $142. Ralph Lauren shares rose 1.2% to $124.00 in pre-market trading. 
    Via Benzinga
    BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today
    Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal. 
    Via InvestorPlace
    The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
    Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
    Via Benzinga
    52 Biggest Movers From Yesterday
    Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences... 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.